Growth Metrics

Opus Genetics (IRD) R&D In Process (2020)

Opus Genetics has reported R&D In Process over the past 1 years, most recently at $8.4 million for Q4 2020.

  • Quarterly R&D In Process changed N/A to $8.4 million in Q4 2020 from the year-ago period, while the trailing twelve-month figure was $8.4 million through Sep 2021, changed N/A year-over-year, with the annual reading at $10.5 million for FY2020, N/A changed from the prior year.
  • R&D In Process was $8.4 million for Q4 2020 at Opus Genetics, up from $2.1 million in the prior quarter.
  • Over five years, R&D In Process peaked at $8.4 million in Q4 2020 and troughed at $2.1 million in Q1 2020.